BioCentury
ARTICLE | Financial News

Applied Molecular IPO prices above range

July 26, 2000 7:00 AM UTC

AMEV priced its IPO at $19 per share in a deal underwritten by CIBC World Markets; PaineWebber; and SG Cowen. The directed evolution company had filed on June 26 to sell 3.75 million shares at $15-$17...